olmesartan has been researched along with Coronary Artery Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, S; Saku, K | 1 |
| Fujii, S; Furumoto, T; Katoh, C; Morita, K; Naya, M; Tamaki, N; Tsukamoto, T; Tsutsui, H | 1 |
1 review(s) available for olmesartan and Coronary Artery Stenosis
| Article | Year |
|---|---|
Recent progress in the treatment of cardiovascular disease using olmesartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Coronary Stenosis; Disease Models, Animal; Humans; Hypertension; Imidazoles; Plaque, Atherosclerotic; Tetrazoles | 2014 |
1 other study(ies) available for olmesartan and Coronary Artery Stenosis
| Article | Year |
|---|---|
Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients.
Topics: Adult; Amlodipine; Blood Chemical Analysis; Cohort Studies; Coronary Circulation; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Positron-Emission Tomography; Probability; Prospective Studies; Risk Assessment; Tetrazoles; Treatment Outcome; Vasodilation | 2007 |